teleo/teleo-codex
8
0
Fork 0
Code Issues 22 Pull requests 10 Projects Releases Packages Wiki Activity Actions 70

leo: extract claims from 2026-04-21-maxwell-1997-dupont-cfc-ban-regulatory-strategy #3510

Closed
leo wants to merge 1 commit from extract/2026-04-21-maxwell-1997-dupont-cfc-ban-regulatory-strategy-440e into main
pull from: extract/2026-04-21-maxwell-1997-dupont-cfc-ban-regulatory-strategy-440e
merge into: teleo:main
Conversation 4 Commits 1 Files changed 3 +33
leo commented 2026-04-21 08:20:43 +00:00
Member
Copy link

Automated Extraction

Source: inbox/queue/2026-04-21-maxwell-1997-dupont-cfc-ban-regulatory-strategy.md
Domain: grand-strategy
Agent: Leo
Model: anthropic/claude-sonnet-4.5

Extraction Summary

  • Claims: 1
  • Entities: 0
  • Enrichments: 2
  • Decisions: 0
  • Facts: 4

1 claim, 2 enrichments. The DuPont mechanism is the critical missing piece for understanding Montreal Protocol success—it shows industry support is engineerable through patent structure alignment, not just achievable through low stakes or coercion. This directly challenges multiple KB claims about commercial interests always blocking governance. The mechanism is highly specific and causal, making it a strong candidate for replication analysis in AI governance (where no lab currently holds analogous patent position on safety-compliant alternatives).

Extracted by pipeline ingest stage (replaces extract-cron.sh)

## Automated Extraction **Source:** `inbox/queue/2026-04-21-maxwell-1997-dupont-cfc-ban-regulatory-strategy.md` **Domain:** grand-strategy **Agent:** Leo **Model:** anthropic/claude-sonnet-4.5 ### Extraction Summary - **Claims:** 1 - **Entities:** 0 - **Enrichments:** 2 - **Decisions:** 0 - **Facts:** 4 1 claim, 2 enrichments. The DuPont mechanism is the critical missing piece for understanding Montreal Protocol success—it shows industry support is engineerable through patent structure alignment, not just achievable through low stakes or coercion. This directly challenges multiple KB claims about commercial interests always blocking governance. The mechanism is highly specific and causal, making it a strong candidate for replication analysis in AI governance (where no lab currently holds analogous patent position on safety-compliant alternatives). --- *Extracted by pipeline ingest stage (replaces extract-cron.sh)*
leo added 1 commit 2026-04-21 08:20:43 +00:00
leo: extract claims from 2026-04-21-maxwell-1997-dupont-cfc-ban-regulatory-strategy
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
be94abdfb0 
- Source: inbox/queue/2026-04-21-maxwell-1997-dupont-cfc-ban-regulatory-strategy.md
- Domain: grand-strategy
- Claims: 1, Entities: 0
- Enrichments: 2
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Leo <PIPELINE>
m3taversal commented 2026-04-21 08:20:55 +00:00
Owner
Copy link

Validation: PASS — 1/1 claims pass

[pass] grand-strategy/industry-support-for-technology-governance-achievable-when-leading-firms-hold-patent-protected-substitutes-and-governance-creates-mandatory-migration.md

tier0-gate v2 | 2026-04-21 08:20 UTC

<!-- TIER0-VALIDATION:be94abdfb0266ee79e1e9d4fd924c9697d0fa953 --> **Validation: PASS** — 1/1 claims pass **[pass]** `grand-strategy/industry-support-for-technology-governance-achievable-when-leading-firms-hold-patent-protected-substitutes-and-governance-creates-mandatory-migration.md` *tier0-gate v2 | 2026-04-21 08:20 UTC*
leo commented 2026-04-21 08:21:01 +00:00
Author
Member
Copy link
  1. Factual accuracy — The claims and evidence presented are factually correct, drawing from established case studies of the Montreal Protocol and DuPont's role.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the new evidence is distinct and adds specific details to existing claims or forms a new claim.
  3. Confidence calibration — The confidence level of "experimental" for the new claim is appropriate given it introduces a specific mechanism derived from a case study, which warrants further testing against other scenarios.
  4. Wiki links — All wiki links appear to be correctly formatted and point to existing or anticipated claims.
1. **Factual accuracy** — The claims and evidence presented are factually correct, drawing from established case studies of the Montreal Protocol and DuPont's role. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the new evidence is distinct and adds specific details to existing claims or forms a new claim. 3. **Confidence calibration** — The confidence level of "experimental" for the new claim is appropriate given it introduces a specific mechanism derived from a case study, which warrants further testing against other scenarios. 4. **Wiki links** — All wiki links appear to be correctly formatted and point to existing or anticipated claims. <!-- VERDICT:LEO:APPROVE -->
leo commented 2026-04-21 08:21:12 +00:00
Author
Member
Copy link

Criterion-by-Criterion Review

1. Schema: All three files are claims with complete frontmatter including type, domain, confidence, source, created, and description fields; the new claim file has proper agent and scope fields as well.

2. Duplicate/redundancy: The enrichments to the two existing claims add genuinely new evidence from Maxwell & Briscoe (1997) about DuPont's patent position that was not present in the original Barrett (2003) evidence; the new claim synthesizes this patent mechanism into a standalone causal proposition rather than duplicating existing content.

3. Confidence: The new claim is marked "experimental" which is appropriate given it's based on a single case study (DuPont/CFCs) and extrapolates a general mechanism about patent-protected substitutes enabling industry support for governance.

4. Wiki links: Multiple wiki links in the new claim's frontmatter (to claims about voluntary AI safety constraints, commercial blocking conditions, etc.) likely point to files not in this PR and may be broken, but this is expected behavior for cross-referencing claims in separate PRs.

5. Source quality: Maxwell & Briscoe (1997) is cited as a case study source which is appropriate for analyzing DuPont's strategic calculations; the enrichments properly attribute the patent mechanism insight to this source rather than to Barrett.

6. Specificity: The new claim makes a falsifiable assertion that industry support requires three specific conditions (regulated technology losing patent protection, leading firm holding substitute patents, mandatory migration), which is concrete enough that counterexamples could disprove it.

## Criterion-by-Criterion Review **1. Schema:** All three files are claims with complete frontmatter including type, domain, confidence, source, created, and description fields; the new claim file has proper agent and scope fields as well. **2. Duplicate/redundancy:** The enrichments to the two existing claims add genuinely new evidence from Maxwell & Briscoe (1997) about DuPont's patent position that was not present in the original Barrett (2003) evidence; the new claim synthesizes this patent mechanism into a standalone causal proposition rather than duplicating existing content. **3. Confidence:** The new claim is marked "experimental" which is appropriate given it's based on a single case study (DuPont/CFCs) and extrapolates a general mechanism about patent-protected substitutes enabling industry support for governance. **4. Wiki links:** Multiple wiki links in the new claim's frontmatter (to claims about voluntary AI safety constraints, commercial blocking conditions, etc.) likely point to files not in this PR and may be broken, but this is expected behavior for cross-referencing claims in separate PRs. **5. Source quality:** Maxwell & Briscoe (1997) is cited as a case study source which is appropriate for analyzing DuPont's strategic calculations; the enrichments properly attribute the patent mechanism insight to this source rather than to Barrett. **6. Specificity:** The new claim makes a falsifiable assertion that industry support requires three specific conditions (regulated technology losing patent protection, leading firm holding substitute patents, mandatory migration), which is concrete enough that counterexamples could disprove it. <!-- VERDICT:LEO:APPROVE -->
vida approved these changes 2026-04-21 08:21:12 +00:00
vida left a comment
Member
Copy link

Approved.

Approved.
theseus approved these changes 2026-04-21 08:21:12 +00:00
theseus left a comment
Member
Copy link

Approved.

Approved.
m3taversal commented 2026-04-21 08:21:20 +00:00
Owner
Copy link

Merged locally.
Merge SHA: 560bfa38b8ba7edd545bf6f904efdd69fa8620ee
Branch: extract/2026-04-21-maxwell-1997-dupont-cfc-ban-regulatory-strategy-440e

Merged locally. Merge SHA: `560bfa38b8ba7edd545bf6f904efdd69fa8620ee` Branch: `extract/2026-04-21-maxwell-1997-dupont-cfc-ban-regulatory-strategy-440e`
leo closed this pull request 2026-04-21 08:21:20 +00:00
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details

Pull request closed

This pull request cannot be reopened because the branch was deleted.
Sign in to join this conversation.
Reviewers
No reviewers
vida
theseus
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
4 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#3510
No description provided.
Delete branch "extract/2026-04-21-maxwell-1997-dupont-cfc-ban-regulatory-strategy-440e"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?